Terms: = Sarcomas AND ERCC4, XPF, 2072, ENSG00000175595, Q92889 AND Treatment
6 results:
1. Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2018 and Annual treatment Report for 2013.
Nagase S; Ohta T; Takahashi F; Yamagami W; Yaegashi N;
J Obstet Gynaecol Res; 2022 Mar; 48(3):541-552. PubMed ID: 35026864
[TBL] [Abstract] [Full Text] [Related]
2. Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma.
Wang MJ; Zhu Y; Guo XJ; Tian ZZ
Genet Mol Res; 2015 Sep; 14(3):11652-7. PubMed ID: 26436406
[TBL] [Abstract] [Full Text] [Related]
3. Systematic review of surgery and outcomes in patients with primary aldosteronism.
Muth A; Ragnarsson O; Johannsson G; Wängberg B
Br J Surg; 2015 Mar; 102(4):307-17. PubMed ID: 25605481
[TBL] [Abstract] [Full Text] [Related]
4. Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up.
Penel N; Le Cesne A; Bui BN; Perol D; Brain EG; Ray-Coquard I; Guillemet C; Chevreau C; Cupissol D; Chabaud S; Jimenez M; Duffaud F; Piperno-Neumann S; Mignot L; Blay JY
Ann Oncol; 2011 Feb; 22(2):452-7. PubMed ID: 20622000
[TBL] [Abstract] [Full Text] [Related]
5. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
[TBL] [Abstract] [Full Text] [Related]
6. Von Hippel-Lindau-coupled and transcription-coupled nucleotide excision repair-dependent degradation of RNA polymerase II in response to trabectedin.
Aune GJ; Takagi K; Sordet O; Guirouilh-Barbat J; Antony S; Bohr VA; Pommier Y
Clin Cancer Res; 2008 Oct; 14(20):6449-55. PubMed ID: 18927284
[TBL] [Abstract] [Full Text] [Related]